Markets

Market Nav

CASH FLOW

You can view the cash flow for the last 5 years.
Kabra Drugs Ltd.
( in Crs.)

ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue10.0010.0010.0010.0010.00
      
Net Profit/Loss Before Extraordinary Items And Tax-1.09-0.74-0.34-0.19-0.18
      
Net CashFlow From Operating Activities-4.71-0.21-0.35-0.13-0.25
Net Cash Used In Investing Activities-0.050.000.000.000.00
Net Cash Used From Financing Activities23.392.880.360.130.25
      
Net Inc/Dec In Cash And Cash Equivalents18.632.670.00-0.010.00
Cash And Cash Equivalents Begin of Year2.670.000.000.010.01
Cash And Cash Equivalents End Of Year21.302.670.000.000.01
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)PR
FaceValue10.00
  
Net Profit/Loss Before Extraordinary Items And Tax-1.09
Net CashFlow From Operating Activities-4.71
Net Cash Used In Investing Activities-0.05
Net Cash Used From Financing Activities23.39
Net Inc/Dec In Cash And Cash Equivalents18.63
Cash And Cash Equivalents Begin of Year2.67
Cash And Cash Equivalents End Of Year21.30